Show threadBjørn BäuchleMay 14

@JeDi Ich hätte gerne mit Familie und Urlaubsgepäck eine Reservierung. Und nun werden wir wahrscheinlich die gleichen Züge für #FF-#XBB nehmen und nur #FKW-#FF anders fahren, sodass es nicht so krass schlimm wäre ohne Reservierung, aber nun ja, sind halt dann die Hälfte der Züge nicht mehr reserviert.

(Und ich schrieb vorhin was von Zugbindung, aber das machen wir eh mit Freifahrten / FIP, also ist die auch irrelevant)

Giuseppe MichieliNov 19, 2025
Increased #pathogenicity and #transmission of #SARS-CoV-2 #Omicron #XBB.1.9 subvariants, including HK.3 and EG.5.1, relative to BA.2, https://etidiohnew.blogspot.com/2025/11/increased-pathogenicity-and.html
Increased #pathogenicity and #transmission of #SARS-CoV-2 #Omicron #XBB.1.9 subvariants, including HK.3 and EG.5.1, relative to BA.2

Vijesti HRAug 2, 2025

Otvoreni natječaji za ulaganja u akvakulturu i preradu proizvoda ribarstva

U Narodnim novinama broj 107/2025 objavljena su tri nova natječaja za mjere potpore iz Europskog fonda za pomorstvo, ribarstvo i akvakulturu. Evo i o kojim se natječajima konkretno radi: Natječaj za dodjelu potpore u okviru mjere II.2. »Produktivna ulaganja u akvakulturu&

Source: https://www.morski.hr/otvoreni-natjecaji-za-ulaganja-u-akvakulturu-i-preradu-proizvoda-ribarstva/

#Hrvatska #Vijesti #News #Croatia

Otvoreni natječaji za ulaganja u akvakulturu i preradu proizvoda ribarstva

U Narodnim novinama broj 107/2025 objavljena su tri nova natječaja za mjere potpore iz Europskog fonda za pomorstvo, ribarstvo i akvakulturu. Evo i o kojim se natječajima konkretno radi: Natječaj za dodjelu potpore u okviru mjere II.2. »Produktivna ulaganja u akvakulturu« Natječaj za dodjelu potpore u okviru mjere

Morski HR
Giuseppe MichieliMar 6, 2025
#XBB.1.5 monovalent #vaccine induces lasting cross-reactive responses to #SARS-CoV-2 #variants such as HV.1 and #JN1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific #antibodies, https://etidiohnew.blogspot.com/2025/03/xbb15-monovalent-vaccine-induces.html
#XBB.1.5 monovalent #vaccine induces lasting cross-reactive responses to #SARS-CoV-2 #variants such as HV.1 and #JN1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific #antibodies

Giuseppe MichieliJan 11, 2025
Respiratory #Shedding of Infectious #SARS-CoV-2 #Omicron #XBB.1.41.1 Lineage among Captive White-Tailed #Deer, #Texas, #USA, https://etidiohnew.blogspot.com/2025/01/respiratory-shedding-of-infectious-sars.html
Respiratory #Shedding of Infectious #SARS-CoV-2 #Omicron #XBB.1.41.1 Lineage among Captive White-Tailed #Deer, #Texas, #USA

Giuseppe MichieliNov 7, 2024

Evolving #antibody #response to #SARS-CoV-2 #antigenic #shift from #XBB to #JN1

Source: Nature, AbstractThe continuous evolution of SARS-CoV-2, particularly the emergence of BA.2.86/JN.1 lineage replacing XBB, necessitates re-evaluation of vaccine compositions 1–3. Here, we provide a comprehensive analysis of the humoral immune response to XBB and JN.1 human exposure. We demonstrate the antigenic distinctiveness of XBB and JN.1 lineages in SARS-CoV-2-naive individuals,…

https://etidioh.wordpress.com/2024/11/07/evolving-antibody-response-to-sars-cov-2-antigenic-shift-from-xbb-to-jn1/

Evolving #antibody #response to #SARS-CoV-2 #antigenic #shift from #XBB to #JN1

Source: Nature, AbstractThe continuous evolution of SARS-CoV-2, particularly the emergence of BA.2.86/JN.1 lineage replacing XBB, necessitates re-evaluation of vaccine compositions 1–3. Here, we pr…

ETIDIoH
Giuseppe MichieliNov 5, 2024

Effect of wild-type #vaccine doses on #BA5 hybrid #immunity, disease #severity, and #XBB #reinfection risk

Source: Journal of Virology, ABSTRACTVaccination against the wild-type (WT) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus did not produce detectable levels of neutralizing antibodies (NAbs) against the BA.5 strain before it emerged. However, coronavirus disease-2019 (COVID-19) severity varied highly between unvaccinated, partially vaccinated,…

https://etidioh.wordpress.com/2024/11/05/effect-of-wild-type-vaccine-doses-on-ba5-hybrid-immunity-disease-severity-and-xbb-reinfection-risk/

Effect of wild-type #vaccine doses on #BA5 hybrid #immunity, disease #severity, and #XBB #reinfection risk

Source: Journal of Virology, ABSTRACTVaccination against the wild-type (WT) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus did not produce detectable levels of neutralizing anti…

ETIDIoH
Giuseppe MichieliOct 15, 2024

#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study

Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…

https://etidioh.wordpress.com/2024/10/15/clinical-profile-analysis-of-sars-cov-2-community-infections-during-periods-with-omicron-ba2-ba4-5-and-xbb-dominance-in-hk-a-prospective-cohort-study/

#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study

Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of gene…

ETIDIoH
Giuseppe MichieliAug 17, 2024

[Correspondence] Virological #characteristics of the #SARS-CoV-2 #KP311 #variant https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00505-X/fulltext?rss=yes

SARS-CoV-2 #JN1 variant (#BA28611), arising from BA.2.86.1 with spike protein (S) substitution S:L455S, outcompeted previously predominant #XBB lineages by beginning of 2024. Subsequently, JN.1 subvariants including #KP2 (JN.1.11.1.2) & #KP3 (JN.1.11.1.3), which acquired additional S substitutions (eg, S:R346T, S:F456L, and S:Q493E) have emerged concurrently (appendix pp 19–20).2

Giuseppe MichieliJul 22, 2024

A trivalent #protein-based pan- #Betacoronavirus #vaccine elicits cross-neutralizing #antibodies against a panel of coronavirus #pseudoviruses https://www.nature.com/articles/s41541-024-00924-x

We demonstrated broad neutralization by a trivalent subunit vaccine, formulating the receptor-binding domains of #SARS-CoV, #MERS-CoV, and SARS-CoV-2 #XBB.1.5 with Alum and CpG55.2.

A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses - npj Vaccines

The development of broad-spectrum coronavirus vaccines is essential to prepare for future respiratory virus pandemics. We demonstrated broad neutralization by a trivalent subunit vaccine, formulating the receptor-binding domains of SARS-CoV, MERS-CoV, and SARS-CoV-2 XBB.1.5 with Alum and CpG55.2. Vaccinated mice produced cross-neutralizing antibodies against all three human Betacoronaviruses and others currently exclusive to bats, indicating the epitope preservation of the individual antigens during co-formulation and the potential for epitope broadening.

Nature